Gallium Ga-68 gozetotide Completed Phase 2 Trials for Latent Cancer (Prostate) Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT03207139Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer